health assessment questionnaire


Also found in: Acronyms.

health assessment questionnaire

A general term for an instrument designed to evaluate a patient’s health status.
References in periodicals archive ?
Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population.
Statistically significant improvements were seen on the Fibromyalgia Impact Questionnaire and the fatigue and function scores of the multidimensional Health Assessment Questionnaire.
The English version of the Personal Impact Health Assessment Questionnaire (PI HAQ) is a tool with high reliability and validity in the assessment of the QoL of RA patients.
The health assessment questionnaire (HAQ) (10) and its derivatives HAQ-II (11) and multidimensional HAQ (MDHAQ) (Figs.
The mean Health Assessment Questionnaire (HAQ) score was 1.
clinical remission) and 55 per cent achieved normal physical functioning, as measured by the Health Assessment Questionnaire.
Other significant correlates of cardiovascular disease risk were a high CRP level at entry, a high score on the Stanford Health Assessment Questionnaire (HAQ), and a high score on the Ritchie index.
Disability was reported on the Health Assessment Questionnaire, and pain and fatigue were rated on a visual analog scale.
Disease activity was evaluated using the Chronic Arthritis Systemic Index (CASI) which was calculated by the following formula: 13 x Health Assessment Questionnaire (HAQ) + 0.
Researchers compared HRQL, the Health Assessment Questionnaire (HAQ), joint count, and pain using a visual analog scale (VAS) among patients in the studies.
Most patients also experienced improved physical function following treatment with ACTEMRA, as measured by the Health Assessment Questionnaire Disability Index (HAQ-DI).
Improvements in quality of life scores (the physical and mental components of Short Form-36) and improvements in physical function (measured by the Health Assessment Questionnaire Disability Index) originally achieved at 6 months in the ATTAIN trial, were sustained for a further 12 months of treatment, according to the results of the one-year extension study.

Full browser ?